BACKGROUND: Compared with those with health insurance, the uninsured receive less care for chronic conditions, such as hypertension and diabetes, and experience higher mortality. METHODS: We investigated the relations of health insurance status to the prevalence, treatment, and control of major cardiovascular disease risk factors-hypertension and elevated low-density lipoprotein (LDL) cholesterol-among Framingham Heart Study (FHS) participants in gender-specific, age-adjusted analyses. Participants who attended the seventh Offspring cohort examination cycle (1998-2001) or the first Third Generation cohort examination cycle (2002-2005) were studied. RESULTS: Among 6098 participants, 3.8% were uninsured at the time of the FHS clinic examination and ages ranged from 19 to 64 years. The prevalence of hypertension and elevated LDL cholesterol was similar for the insured and uninsured; however, the proportion of those who obtained treatment and achieved control of these risk factors was lower among the uninsured. Uninsured men and women were less likely to be treated for hypertension with odds ratios for treatment of 0.19 (95% confidence interval [CI], 0.07-0.56) for men and 0.31 (95% CI, 0.12-0.79) for women. Among men, the uninsured were less likely to receive treatment or achieve control of elevated LDL cholesterol than the insured, with odds ratios of 0.12 (95% CI, 0.04-0.38) for treatment and 0.17 (95% CI, 0.05-0.56) for control. CONCLUSION: The treatment and control of hypertension and hypercholesterolemia are lower among uninsured adults. Increasing the proportion of insured individuals may be a means to improve the treatment and control of cardiovascular disease risk factors and to reduce health disparities. Published by Elsevier Inc.
BACKGROUND: Compared with those with health insurance, the uninsured receive less care for chronic conditions, such as hypertension and diabetes, and experience higher mortality. METHODS: We investigated the relations of health insurance status to the prevalence, treatment, and control of major cardiovascular disease risk factors-hypertension and elevated low-density lipoprotein (LDL) cholesterol-among Framingham Heart Study (FHS) participants in gender-specific, age-adjusted analyses. Participants who attended the seventh Offspring cohort examination cycle (1998-2001) or the first Third Generation cohort examination cycle (2002-2005) were studied. RESULTS: Among 6098 participants, 3.8% were uninsured at the time of the FHS clinic examination and ages ranged from 19 to 64 years. The prevalence of hypertension and elevated LDL cholesterol was similar for the insured and uninsured; however, the proportion of those who obtained treatment and achieved control of these risk factors was lower among the uninsured. Uninsured men and women were less likely to be treated for hypertension with odds ratios for treatment of 0.19 (95% confidence interval [CI], 0.07-0.56) for men and 0.31 (95% CI, 0.12-0.79) for women. Among men, the uninsured were less likely to receive treatment or achieve control of elevated LDL cholesterol than the insured, with odds ratios of 0.12 (95% CI, 0.04-0.38) for treatment and 0.17 (95% CI, 0.05-0.56) for control. CONCLUSION: The treatment and control of hypertension and hypercholesterolemia are lower among uninsured adults. Increasing the proportion of insured individuals may be a means to improve the treatment and control of cardiovascular disease risk factors and to reduce health disparities. Published by Elsevier Inc.
Authors: John Z Ayanian; Alan M Zaslavsky; Joel S Weissman; Eric C Schneider; Jack A Ginsburg Journal: Am J Public Health Date: 2003-12 Impact factor: 9.308
Authors: Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy Journal: Am J Epidemiol Date: 2007-03-19 Impact factor: 4.897
Authors: Sameed Ahmed M Khatana; Anjali Bhatla; Ashwin S Nathan; Jay Giri; Changyu Shen; Dhruv S Kazi; Robert W Yeh; Peter W Groeneveld Journal: JAMA Cardiol Date: 2019-07-01 Impact factor: 14.676
Authors: John Billimek; Shaista Malik; Dara H Sorkin; Priel Schmalbach; Quyen Ngo-Metzger; Sheldon Greenfield; Sherrie H Kaplan Journal: Womens Health Issues Date: 2014-11-22
Authors: Matt Mefford; Monika M Safford; Paul Muntner; Raegan W Durant; Todd M Brown; Emily B Levitan Journal: Int J Cardiol Date: 2017-02-22 Impact factor: 4.164
Authors: Kim G Smolderen; John A Spertus; Fengming Tang; William Oetgen; William B Borden; Henry H Ting; Paul S Chan Journal: J Am Coll Cardiol Date: 2013-01-30 Impact factor: 24.094
Authors: Timothy M Connolly; Robert S White; Dahniel L Sastow; Licia K Gaber-Baylis; Zachary A Turnbull; Lisa Q Rong Journal: World J Surg Date: 2018-10 Impact factor: 3.352